Rating Change
Guggenheim reiterated its Buy rating on SCYNEXIS, Inc. (NASDAQ:SCYX) on August 13, 2026.
Guggenheim reiterated its Buy rating on SCYNEXIS, Inc. (NASDAQ:SCYX) on August 13, 2026.

At publication ·
SCYNEXIS, Inc. (NASDAQ:SCYX) · reiterate
At a glance
Guggenheim reiterated its Buy rating on SCYNEXIS, Inc. (NASDAQ:SCYX) on August 13, 2026.
SCYNEXIS, Inc. operates in the Healthcare sector. The stock currently trades at $5.12 with a market capitalization of $27.3M.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for SCYNEXIS, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | Guggenheim | Buy | N/A |
| Oct 28, 2025 | Guggenheim | Buy | N/A |
| Apr 01, 2024 | Cantor Fitzgerald | Overweight | N/A |
| Aug 15, 2023 | Cantor Fitzgerald | Overweight | N/A |
| Apr 03, 2023 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View SCYX Stock Page
A rating of Buy from Guggenheim reflects the analyst's outlook on SCYNEXIS, Inc. (NASDAQ:SCYX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SCYX forecast page.
Current market data
NASDAQ · SCYX
$5.12
Up: +$0.04 · +0.78%
Live quote updated
Keep reading